However, longer median overall survival (OS) was observed in patients harboring EGFRvIII compared to those without EGFRvIII, although the difference did not reach statistical significance.
← all excerpts
Epidermal growth factor receptor variant III mutation in Chinese patients with squamous cell cancer of the lung.
1
—
—